Tuesday, April 7, 2009

Reorganizing Drug R&D: $62 Billion Merger Not Required

As their pipelines have grown thin, big drug companies have busied themselves reorganizing R&D.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)